APTORUM GROUP LIMITED

(APM)
  Report
Delayed Nasdaq  -  05/27 04:00:00 pm EDT
1.270 USD   +4.10%
05/17Aptorum Group Limited to Present at the H.C. Wainwright Global Investment Conference, May 23 – 26 2022
BU
05/02Aptorum Says Rare Cancer Drug Well Tolerated in Early-Stage Study
MT
05/02Aptorum Group Updates on Data from the Completed Phase 1 Clinical Trial of SACT-1, targeting neuroblastoma
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Health Care Stocks Posting Gains This Afternoon

01/20/2022 | 01:13pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
APTORUM GROUP LIMITED 4.10% 1.27 Delayed Quote.-15.33%
NASDAQ COMP. 3.33% 12131.13 Real-time Quote.-22.46%
NOVOCURE LIMITED 4.73% 83.98 Delayed Quote.11.85%
STAR EQUITY HOLDINGS, INC. 5.14% 0.9895 Delayed Quote.-61.20%
All news about APTORUM GROUP LIMITED
05/17Aptorum Group Limited to Present at the H.C. Wainwright Global Investment Conference, M..
BU
05/02Aptorum Says Rare Cancer Drug Well Tolerated in Early-Stage Study
MT
05/02Aptorum Group Updates on Data from the Completed Phase 1 Clinical Trial of SACT-1, targ..
BU
05/02Aptorum Group Limited Updates on Data from Completed Phase 1 Clinical Trial of SACT-1, ..
CI
04/29APTORUM : Reports 2021 Fiscal Year End Financial Results and Provides Business Update - Fo..
PU
04/29Aptorum Group Limited Reports Earnings Results for the Full Year Ended December 31, 202..
CI
04/29Aptorum Group Limited Reports 2021 Fiscal Year End Financial Results and Provides Busin..
BU
04/29APTORUM GROUP LIMITED : SEC Filing 6K-4
CO
04/29APTORUM GROUP LIMITED : Annual results
CO
04/29APTORUM GROUP LIMITED : SEC Filing 20 F
CO
More news
Financials (USD)
Sales 2022 1,50 M - -
Net income 2022 -35,5 M - -
Net Debt 2022 - - -
P/E ratio 2022 -1,27x
Yield 2022 -
Capitalization 45,3 M 45,3 M -
Capi. / Sales 2022 30,2x
Capi. / Sales 2023 23,9x
Nbr of Employees 26
Free-Float 25,4%
Chart APTORUM GROUP LIMITED
Duration : Period :
Aptorum Group Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends APTORUM GROUP LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 1,27 $
Average target price 15,00 $
Spread / Average Target 1 081%
EPS Revisions
Managers and Directors
Ian Huen Director
Darren Lui President & Executive Director
Sabrina Khan Chief Financial Officer
Clark Cheng Executive Director & Chief Medical Officer
Wai-Yip Lee Head-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
APTORUM GROUP LIMITED-15.33%45
NOVO NORDISK A/S-3.80%1 677 391
JOHNSON & JOHNSON5.86%476 521
PFIZER, INC.-8.70%302 483
ELI LILLY AND COMPANY17.11%291 184
ROCHE HOLDING AG-13.00%281 098